Quibim

Prostate cancer is the second most prevalent cancer in men globally. Recent advancements in MRI technology have substantially improved the ability to detect and characterise prostate tumours. The Prostate Imaging-Reporting and Data System version 2.1 (PI-RADS v2.1) has been critical in improving the detection, localisation, characterisation, and risk stratification of lesions in untreated prostate glands, […]

Advances in MRI technology have significantly enhanced the ability to detect and characterise prostate tumours. The PI-RADS v2.1 reporting system aims to improve the detection, localisation, characterisation and risk stratification of lesions in treatment-naïve prostate glands, streamlining communication between clinicians and radiologists. QP-Prostate, an AI-powered solution from Quibim, is designed to enhance the accuracy, efficiency […]